Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126153281 | 12615328 | 1 | I | 20160718 | 20160802 | 20160802 | EXP | IN-AKORN PHARMACEUTICALS-2016AKN00469 | AKORN | TRIPATHY K, SHARMA YR, SINGH HI, VOHRA R, VENKATESH P, BASHEER S. SCLERAL ABSCESS FOLLOWING POSTERIOR SUBTENON TRIAMCINOLONE ACETONIDE INJECTION FOR DIABETIC MACULAR EDEMA. SAUDI J OPHTHALMOL (DOI: 10.1016/J.SJOPT.2015.12.007). 2016;30(9):130-132 | 65.00 | YR | M | Y | 0.00000 | 20160802 | OT | IN | IN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126153281 | 12615328 | 1 | PS | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | Intraocular | 20 MG/0.5 ML, OD,UNK | U | 202374 | 20 | MG | |||||||
126153281 | 12615328 | 2 | C | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | Ophthalmic | OD, UNK | 0 | ||||||||||
126153281 | 12615328 | 3 | C | HYPOGLYCEMIC AGENTS | 2 | Oral | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126153281 | 12615328 | 1 | Macular oedema |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126153281 | 12615328 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126153281 | 12615328 | Eye abscess |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |